RK

Rajeev Kant Pandey

Active Director Director DIN 06674936
DIN 06674936 First appointment Sep 2013 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajeev Kant Pandey

Data last updated:

Rajeev Kant Pandey is a Director at Rkpd Pharmaceuticals & Trading Private Limited (since 2013). The company operates in Professional Services.

DIN 06674936
Primary Designation Director
Industry Professional Services
First Appointment 09 Sep 2013
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Sep 20132013Active

Board colleagues of Rajeev Kant Pandey

Directorship timeline

Open interactive timeline →
Rkpd Pharmaceuticals & Trading Private Limited
Premium access

Shareholding and investment profile for Rajeev Kant Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Kant Pandey

Rajeev Kant Pandey currently holds 1 directorship: Rkpd Pharmaceuticals & Trading Private Limited (Director, since 09 Sep 2013).

Rajeev Kant Pandey was first appointed on 09 Sep 2013 as Director at Rkpd Pharmaceuticals & Trading Private Limited.

The current boards of Rajeev Kant Pandey's companies include Awaniranjan Dwivedi Jagdishprasad (Rkpd Pharmaceuticals & Trading Private Limited), Piyush Dwivedi (Rkpd Pharmaceuticals & Trading Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available